DOCU vs MRNA · P/E 15, rev $1.71B vs rev $145.0M
DocuSign Inc (DOCU) versus Moderna Inc (MRNA) — a side-by-side from cached financials, not a winner call.
DocuSign Inc (DOCU) is a software - application company listed on US.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stephane Bancel.
Latest reported DOCU revenue for 2026-07-31 was $1.71B. Net income was $155.9M. DOCU currently screens at market cap $15.74B and trailing P/E 14.8.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
DOCU currently screens at market cap $15.74B and trailing P/E 14.8. MRNA currently screens at market cap $24.52B.
Not investment advice. Open the DOCU and MRNA stock pages for the full models.
Not investment advice.